For citations:
Ivanova D.A., Borisov S.E., Ryzhov A.M. Hyperuricemia during anti-tuberculosis therapy: clinical significance, risk factors and monitoring strategies. Tuberculosis and socially significant diseases. 2017;(3):24-31. (In Russ.)
Views PDF (Rus): 8
Email this article 